Alerts will be sent to your verified email
Verify Email
GENNEX
|
Gennex Lab
|
Vaidya Sane Ayur Lab
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.82 % | 8.39 % | 27.3 % |
|
5yr average Equity Multiplier
|
1.53 | 1.34 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
0.75 | 1.57 | 1.43 |
|
5yr Avg Net Profit Margin
|
7.88 % | 3.83 % | 11.03 % |
|
Price to Book
|
1.55 | 0.0 | 1.13 |
|
P/E
|
17.23 | 39.91 | 13.95 |
|
5yr Avg Cash Conversion Cycle
|
43.23 Days | -76.76 Days | 154.28 Days |
|
Inventory Days
|
49.12 Days | 11.33 Days | 87.41 Days |
|
Days Receivable
|
50.53 Days | 24.16 Days | 103.86 Days |
|
Days Payable
|
75.36 Days | 116.68 Days | 63.18 Days |
|
5yr Average Interest Coverage Ratio
|
6.21 | 6.88 | 57.05 |
|
5yr Avg ROCE
|
11.17 % | 12.91 % | 36.52 % |
|
5yr Avg Operating Profit Margin
|
10.47 % | 7.94 % | 16.64 % |
|
5 yr average Debt to Equity
|
0.18 | 0.02 | 0.09 |
|
5yr CAGR Net Profit
|
43.63 % | -10.61 % | -5.76 % |
|
5yr Average Return on Assets
|
5.16 % | 6.19 % | 18.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
19.83 % | 66.34 % | 65.99 % |
|
Share Pledged by Promoters
|
21.79 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.22 % | 0.0 | -6.87 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Gennex Lab
|
Vaidya Sane Ayur Lab
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Asset Break-Up - Geography Wise
|
Asset Break-Up - Geography Wise
|
-
|
-
|